Managed entry agreements for pharmaceuticals, biotechnologies, and devices have attracted considerable interest in recent years.

Different approaches have been trialed and numerous agreements implemented, both successfully and unsuccessfully.

This eBook illustrates some of the concepts of MEAs and provides an overview of the key principles of engagement that manufacturers could consider